Skip to content

Peripheral Tissue Perfusion in Intensive Care

Effects of Therapeutic Hemodynamic Interventions on Peripheral Perfusion in Intensive Care

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06384287
Acronym
INPPEREA
Enrollment
180
Registered
2024-04-25
Start date
2024-06-22
Completion date
2027-07-31
Last updated
2025-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Circulatory Failure

Keywords

Tissue perfusion, Capillary refill time, Skin blood flow, Fluid challenge, Inotrope

Brief summary

Tissue perfusion has been identified as an early prognosis factor in patients admitted to intensive care. However, little is known about the effects of different hemodynamic interventions performed in clinical routine on peripheral tissue perfusion. The aim of this work is to study the kinetics of CRT and local skin blood flow following therapeutic intervention (fluid challenge, vasopressor or inotropic drug).

Detailed description

Sepsis is today a major cause of morbidity and mortality worldwide. Septic shock, the most serious manifestation of the infection, affects 2 to 20% of intensive care patients. Despite appropriate antibiotic therapy and improved resuscitation strategies based on early treatment, volume expansion and rational use of vasopressors, the mortality rate of shock states remains too high, between 40 and 50%. Over the past two decades, great advances have been made in the understanding the pathophysiology of septic shock. Microcirculatory abnormalities have been identified as the main cause of organ hypoperfusion and visceral failure leading to death. In addition, several studies in animals and humans have highlighted a discordance between systemic hemodynamic parameters and alterations of small vessels during shock suggesting that microvascular blood flow and tissue perfusion should be analyzed in patients with acute circulatory failure in association with blood pressure and cardiac output. Capillary refill time (CRT), is an easy-to-use, easy-to learn tool to evaluate peripheral tissue perfusion. CRT is a strong predictive factor of organ failure severity and poor outcome in critically ill patients with sepsis. A recent randomized trial reported promising results regarding the use of CRT to guide resuscitation. However, little is known about the impact of treatment on CRT. The aim of this work is to study the kinetics of CRT and local skin blood flow following therapeutic intervention (fluid challenge, vasopressor or inotropic drug).

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients in intensive care unit with acute circulatory failure related to sepsis or cardiac failure requiring therapeutic intervention

Exclusion criteria

* Agitation * Hemorrhagic shock * Severe skin lesions

Design outcomes

Primary

MeasureTime frameDescription
Skin blood flow variationscontinuous monitoring during 1 hour maximum starting just before interventionMeasurement using laser doppler probe in the finger tip

Secondary

MeasureTime frameDescription
Capillary refill timeat baseline, 3 timepoints after starting interventions (10, 30 and 60 minutes)Clinical measurement at bedside
Mottling scoreat baseline, 3 timepoints after starting interventions (10, 30 and 60 minutes)Clinical measurement at bedside
correlation between Skin blood flow and CRT (baseline and variations)at baseline, at 10, 30 and 60 minutes after interventionMeasurement using laser doppler probe in the finger tip
correlation between skin blood flow and Cardiac outputat baseline, at 10, 30 and 60 minutes after interventionLaser doppler with skin probe and echocardiography
correlation between skin blood flow and mean arterial pressureat baseline, at 10, 30 and 60 minutes after interventionLaser doppler with skin probe and arterial catheter

Countries

France

Contacts

Primary ContactHafid Ait-Oufella
hafid.aitoufella@aphp.fr+33612011940

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026